PHAT
Phathom Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$5.68
−1.05%Forward multiples
Based on analyst estimates
- P/E forward
- 26.22x
- P/E 2026E
- —
- P/E 2027E
- 8.70x
- P/E 2028E
- 2.88x
- P/S forward
- 1.06x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -1.33x
- Price / sales
- 1.68x
- Price / cash flow
- -22.26x
Enterprise value
- Enterprise value
- $445.1M
- EV / sales
- 1.62x
- EV / EBITDA
- -22.46x
- EV / EBIT
- -17.49x
- Market cap
- $461.7M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Sep 1, 2026